Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Cited by (1,000)

Items 301–400 of 1,000

1. Lack of Decay of HIV-1 in Gut-Associated Lymphoid Tissue Reservoirs in Maximally Suppressed Individuals
   Michael A. Poles, W. John Boscardin, Julie E. Elliott, Philip Taing, Marie M. P. Fuerst, Ian McGowan, Stephen Brown, Peter A. Anton · 2006 · JAIDS Journal of Acquired Immune Deficiency Syndromes
2. Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
   Hans‐Jürgen Stellbrink, Jan van Lunzen, Michael Westby, Eithne O’Sullivan, Claus G. Schneider, Axel Adam, Lutwin Weitner, Birger Kuhlmann, Christian Hoffmann, Stefan Fenske et al. · 2002 · AIDS
3. Human adipose tissue as a reservoir for memory CD4+ T cells and HIV
   Jacob P. Couturier, James W. Suliburk, Jeremy M. Brown, David J. Luke, Neeti Agarwal, Xiaoying Yu, Chi Nguyen, Dinakar Iyer, Claudia A. Kozinetz, Paul A. Overbeek et al. · 2015 · AIDS
4. HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission
   Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, Andrew J. Grimm, David A. Cooper, Sharon R. Lewin, Ole Schmeltz Søgaard, Thomas A. Rasmussen, Stephen John Kent, Anthony Dominic Kelleher et al. · 2015 · PLoS Pathogens
5. Turnover Rates of B Cells, T Cells, and NK Cells in Simian Immunodeficiency Virus-Infected and Uninfected Rhesus Macaques
   Rob J. de Boer, Hiroshi Mohri, David D. Ho, Alan S. Perelson · 2003 · The Journal of Immunology
6. Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
   Ahmad R. Sedaghat, Jason B. Dinoso, Lin Shen, Claus O. Wilke, Robert F. Siliciano · 2008 · Proceedings of the National Academy of Sciences
7. A Flexible Model of HIV-1 Latency Permitting Evaluation of Many Primary CD4 T-Cell Reservoirs
   Kara G. Lassen, Andrew M. Hebbeler, Darshana Bhattacharyya, Michael A. Lobritz, Warner C. Greene · 2012 · PLoS ONE
8. Unintegrated Lentivirus DNA Persistence and Accessibility to Expression in Nondividing Cells: Analysis with Class I Integrase Mutants
   Dyana T. Saenz, Nils A. Loewen, Mary Peretz, Todd Whitwam, Román Barraza, Kyle G. Howell, Jonathan M. Holmes, Margaret S. Good, Eric M. Poeschla · 2004 · Journal of Virology
9. HIV entry inhibitors and their potential in HIV therapy
   Keduo Qian, Susan Lynne Morris-Natschke, Kuo‐Hsiung Lee · 2008 · Medicinal Research Reviews
10. Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection
    Luc Geeraert, Günter Kraus, Roger J. Pomerantz · 2007 · Annual Review of Medicine
11. Is the central nervous system a reservoir of HIV-1?
    Lachlan R. Gray, Michael Roche, Jacqueline K. Flynn, Steve L Wesselingh, Paul R. Gorry, Melissa J. Churchill · 2014 · Current Opinion in HIV and AIDS
12. Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
    Xiaodong Lian, Kyra W. Seiger, Elizabeth M. Parsons, Ce Gao, Weiwei Sun, Gregory T. Gladkov, Isabelle C. Roseto, Kevin B. Einkauf, Matthew R. Osborn, Joshua M Chevalier et al. · 2023 · Cell Host & Microbe
13. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline
    Richard B. Markham, Wei-Cinn Wang, Anton E. Weisstein, Zhe Wang, Álvaro Muñoz, Alan R. Templeton, Joseph B. Margolick, David Vlahov, Thomas C. Quinn, Homayoon Farzadegan et al. · 1998 · Proceedings of the National Academy of Sciences
14. Resting CD4 + T Lymphocytes but Not Thymocytes Provide a Latent Viral Reservoir in a Simian Immunodeficiency Virus- Macaca nemestrina Model of Human Immunodeficiency Virus Type 1-Infected Patients on Highly Active Antiretroviral Therapy
    Anding Shen, M. Christine Zink, Joseph L. Mankowski, Karen R. Chadwick, Joseph B. Margolick, Lucy M. Carruth, Ming Li, Janice E. Clements, Robert F. Siliciano · 2003 · Journal of Virology
15. Human Immunodeficiency Virus Type 1 Quasi Species That Rebound after Discontinuation of Highly Active Antiretroviral Therapy Are Similar to the Viral Quasi Species Present before Initiation of Therapy
    Hiromi Imamichi, Keith A. Crandall, Ven Natarajan, Min Jiang, Robin L. Dewar, Steve C. Berg, Arunasri Gaddam, Marjorie C. Bosche, Julia A. Metcalf, Richard T. Davey et al. · 2001 · The Journal of Infectious Diseases
16. Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNA
    Christian M. Leutenegger, Joanne Higgins, Timothy B. Matthews, Alice F. Tarantal, Paul A. Luciw, Niels C. Pedersen, Thomas W. North · 2001 · AIDS Research and Human Retroviruses
17. Activation and Cell Cycle Antigens in CD4+and CD8+T Cells Correlate with Plasma Human Immunodeficiency Virus (HIV‐1) RNA Level in HIV‐1 Infection
    Jurgen M. Orendi, Andries C. Bloem, Jan C.C. Borleffs, Folko‐Jan Wijnholds, Nanda Vos, Hans S.L.M. Nottet, M. R. Visser, Harm Snippe, J. Verhoef, Charles A. Boucher · 1998 · The Journal of Infectious Diseases
18. Elite controllers as a model of functional cure
    Brigitte Autran, Benjamin Descours, Véronique Avettand-Fènoël, Christine Rouzioux · 2011 · Current Opinion in HIV and AIDS
19. HIV reservoirs and latency models
    Matthew J. Pace, Luis M. Agosto, Erin H. Graf, Una O’Doherty · 2011 · Virology
20. Influence of Host Gene Transcription Level and Orientation on HIV-1 Latency in a Primary-Cell Model
    Liang Shan, Hung‐Chih Yang, Seyed Alireza Rabi, Héctor Corrada Bravo, Neeta S. Shroff, Rafael A. Irizarry, Hao Zhang, Joseph B. Margolick, Janet D'Angelo Siliciano, Robert F. Siliciano · 2011 · Journal of Virology
21. Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals
    Manuela Fogli, Domenico Mavilio, Enrico Brunetta, Stefania Varchetta, Khaled Ata, Gregg A. Roby, Colin M Kovacs, Dean A. Follmann, Daniela Pende, Jeffrey P. Ward et al. · 2008 · PLoS Pathogens
22. HIV Latency in the Humanized BLT Mouse
    Matthew D. Marsden, Michael Kovochich, Nuttee Suree, Saki Shimizu, Roshni Mehta, Ruth Cortado, Gregory C. Bristol, Dong Sung An, Jerome A. Zack · 2011 · Journal of Virology
23. LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
    Vranckx, Lenard S., Demeulemeester, Jonas, Saleh, Suha, Boll, Annegret, Vansant, Gerlinde, Schrijvers, Rik, Weydert, Caroline, Battivelli, Emilie, Verdin, Eric, Cereseto, Anna et al. · 2016 · EBioMedicine
24. Viral complementation allows HIV-1 replication without integration
    Huub C. Gelderblom, Dimitrios N. Vatakis, Sean A. Burke, Steven D Lawrie, Gregory C. Bristol, David N. Levy · 2008 · Retrovirology
25. Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir
    Christian Gaebler, Julio C. C. Lorenzi, Thiago Y. Oliveira, Lilian Nogueira, Víctor Ramos, Ching-Lan Lu, Joy A. Pai, Pilar Mendoza, Mila Janković, Marina F. Caskey et al. · 2019 · The Journal of Experimental Medicine
26. Establishment of latent HIV-1 reservoirs: what do we really know?
    Jef Vanhamel, Anne Bruggemans, Zeger Debyser · 2019 · Journal of Virus Eradication
27. Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
    Joshua Tisdell Schiffer, Martine Aubert, Nicholas D. Weber, Esther Mintzer, Daniel Stone, Keith R. Jerome · 2012 · Journal of Virology
28. HIV latency and integration site placement in five cell-based models
    Scott A. Sherrill-Mix, Mary K. Lewinski, Marylinda Famiglietti, Alberto Bosque, Nirav Malani, Karen E. Ocwieja, Charles C. Berry, David J. Looney, Liang Shan, Luis M. Agosto et al. · 2013 · Retrovirology
29. Treatment of Primary Human Immunodeficiency Virus Type 1 Infection with Potent Antiretroviral Therapy Reduces Frequency of Rapid Progression to AIDS
    M. Michelle Berrey, Timothy W. Schacker, Ann C. Collier, Theresa Shea, Scott J. Brodie, Douglas L. Mayers, Robert W. Coombs, John N. Krieger, Tae‐Wook Chun, Anthony S. Fauci et al. · 2001 · The Journal of Infectious Diseases
30. Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
    Daniel Aaron Donahue, Mark A. Wainberg · 2013 · Retrovirology
31. Semen-Specific Genetic Characteristics of Human Immunodeficiency Virus Type 1 env
    Satish K. Pillai, Benjamin M. Good, Sergei L. Kosakovsky Pond, Joseph K. Wong, Matthew C. Strain, Douglas D. Richman, Davey M. Smith · 2005 · Journal of Virology
32. P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals
    E. Rhiannon Meaden · 2002 · Journal of Antimicrobial Chemotherapy
33. Methods for Gene Transfer to the Central Nervous System
    Kantor, Boris, Bailey, Rachel M., Wimberly, Keon, Kalburgi, Sahana N., Gray, Steven J. · 2014 · Advances in Genetics
34. Simian Immunodeficiency Virus–Infected Macaques Treated with Highly Active Antiretroviral Therapy Have Reduced Central Nervous System Viral Replication and Inflammation but Persistence of Viral DNA
    M. Christine Zink, Angela K. Brice, Kathleen M. Kelly, Suzanne E. Queen, Lúcio Gama, Ming Li, Robert J. Adams, Christopher M. Bartizal, John J. Varrone, Seyed Alireza Rabi et al. · 2010 · The Journal of Infectious Diseases
35. Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
    Alexandra Emilie Duverger, Jennifer Jones, Jori E. May, Frédéric Bibollet‐Ruche, Frederic A. Wagner, Randy Quentin Cron, Olaf Kutsch · 2009 · Journal of Virology
36. Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
    Shay Matalon, Thomas A. Rasmussen, Charles Anthony Dinarello · 2011 · Molecular Medicine
37. Transcription-Dependent Gene Looping of the HIV-1 Provirus Is Dictated by Recognition of Pre-mRNA Processing Signals
    Kelly J. Perkins, Marina Lušić, Ivonne Mitar, Mauro Giacca, Nicholas J. Proudfoot · 2008 · Molecular Cell
38. HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration
    Luis M. Agosto, Jianqing J. Yu, Jihong Dai, Rachel L. Kaletsky, Daphne Monie, Una O’Doherty · 2007 · Virology
39. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
    Mohamed Abdel‐Mohsen, Leticia Kuri-Cervantes, Judith Grau-Expósito, Adam M. Spivak, Racheal A. Nell, Costin Tomescu, Surya Kumari Vadrevu, Leila B. Giron, Carla Serra‐Peinado, Meritxell Genescà et al. · 2018 · Science Translational Medicine
40. Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency
    Sushama Telwatte, Sulggi A. Lee, Ma Somsouk, Hiroyu Hatano, Chris A. R. Baker, Philipp D. Kaiser, Peggy Kim, Tsui‐Hua Chen, Jeffrey M. Milush, Peter W. Hunt et al. · 2018 · PLoS Pathogens
41. Long‐term survival and virus production in human primary macrophages infected by human immunodeficiency virus
    Stefano Aquaro, Patrizia Bagnarelli, Tania Guenci, Andrea De Luca, Massimo Clementi, Emanuela Balestra, Raffaele Caliò, Carlo Federico Perno · 2002 · Journal of Medical Virology
42. CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells
    Leslie R. Cockerham, Janet D'Angelo Siliciano, Elizabeth Sinclair, Una O’Doherty, Sarah Palmer, Steven A. Yukl, Matthew C. Strain, Nicolas Chomont, Frederick M. Hecht, Robert F. Siliciano et al. · 2014 · PLoS ONE
43. Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome
    Alexander O. Pasternak, Suzanne Jurriaans, Margreet E. Bakker, Jan M. Prins, Ben Berkhout, Vladimir V. Lukashov · 2009 · PLoS ONE
44. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption
    D. Brenda Salantes, Yu Zheng, Felicity Mampe, Tuhina Srivastava, Subul A. Beg, Jun Lai, Jonathan Z. Li, Randall L. Tressler, Richard A. Koup, James A. Hoxie et al. · 2018 · Journal of Clinical Investigation
45. Functional heterogeneity of colony‐stimulating factor‐induced human monocyte‐derived macrophages
    Kiyoko S. Akagawa, Iwao Komuro, Hiroko Kanazawa, Toshio Yamazaki, Keiko Mochida, Fumio Kishi · 2006 · Respirology
46. In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
    Mark E. Sharkey, Karine Triques, Daniel R. Kuritzkes, Mario Stevenson · 2005 · Journal of Virology
47. Targeting the Brain Reservoirs: Toward an HIV Cure
    Céline Marban, Faezeh Forouzanfar, Amina Aït-Ammar, Faiza Fahmi, Hala El Mekdad, Fadoua Daouad, Olivier Rohr, Christian Schwartz · 2016 · Frontiers in Immunology
48. Viral and Latent Reservoir Persistence in HIV-1 Infected Patients on Therapy
    Hwijin Kim, Alan S. Perelson · 2005 · PLoS Computational Biology
49. Identification of T cell-signaling pathways that stimulate latent HIV in primary cells
    David G. Brooks, Philip A. Arlen, Lianying Gao, Christina M. Ramirez, Jerome A. Zack · 2003 · Proceedings of the National Academy of Sciences
50. An AP-1 Binding Site in the Enhancer/Core Element of the HIV-1 Promoter Controls the Ability of HIV-1 To Establish Latent Infection
    Alexandra Emilie Duverger, Frank Wolschendorf, Mingce Zhang, Fredric Wagner, Brandon Hatcher, Jennifer Jones, Randy Quentin Cron, Renée Marije van der Sluis, Rienk E. Jeeninga, Ben Berkhout et al. · 2012 · Journal of Virology
51. Kinetics of Human Immunodeficiency Virus Type 1 (HIV) DNA Integration in Acutely Infected Cells as Determined Using a Novel Assay for Detection of Integrated HIV DNA
    Nick Vandegraaff, Raman Kumar, Christopher J. Burrell, Peng Li · 2001 · Journal of Virology
52. An In Vitro Rapid-Turnover Assay for Human Immunodeficiency Virus Type 1 Replication Selects for Cell-to-Cell Spread of Virus
    Suryaram Gummuluru, C. Matthew Kinsey, Michael Emerman · 2000 · Journal of Virology
53. British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005)
    Brian Gazzard · 2005 · HIV Medicine
54. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy
    Gerrit Jan Weverling, Joep M. A. Lange, Suzanne Jurriaans, Jan M. Prins, Vladimir V. Lukashov, Daan W. Notermans, Marijke T.L. Roos, Hanneke Schuitemaker, Richard M. W. Hoetelmans, Sven A. Danner et al. · 1998 · AIDS
55. Efficacy of Low‐Dose Subcutaneous Interleukin‐2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load
    Albert Arnó, Lı́dia Ruiz, Manel Juan, Antoni Jou, Montserrat Balagué, MohʼD Khalil Zayat, Sílvia Marfil, Javier Martínez‐Picado, Miguel Ángel Martı́nez, Joan Romeu et al. · 1999 · The Journal of Infectious Diseases
56. Kinetics of Virus-Specific CD8⁺T Cells and the Control of Human Immunodeficiency Virus Infection
    Davenport, Miles P., Ribeiro, Ruy M., Perelson, Alan S. · 2004 · Journal of Virology
57. Human Immunodeficiency Virus Integrates Directly into Naive Resting CD4+T Cells but Enters Naive Cells Less Efficiently than Memory Cells
    Jihong Dai, Luis M. Agosto, Clifford Baytop, Jianqing J. Yu, Matthew J. Pace, Megan K. Liszewski, Una O’Doherty · 2009 · Journal of Virology
58. Are T cells the only HIV-1 reservoir?
    Abraham Joseph Kandathil, Sho Sugawara, Ashwin Balagopal · 2016 · Retrovirology
59. Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy
    Christine M. Fennessey, Mykola Pinkevych, Taina T. Immonen, Arnold Reynaldi, Vanessa Venturi, Priyanka Nadella, Carolyn Reid, Laura P. Newman, Leslie Lipkey, Kelli A. Oswald et al. · 2017 · PLoS Pathogens
60. Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes
    Lara Manganaro, Marina Lušić, María Inés Gutiérrez, Anna Cereseto, Giannino Del Sal, Mauro Giacca · 2010 · Nature Medicine
61. Antiretroviral Therapy in Macrophages: Implication for HIV Eradication
    Christina Gavegnano, Raymond F. Schinazi · 2009 · Antiviral chemistry & chemotherapy
62. Seroreversion in Subjects Receiving Antiretroviral Therapy during Acute/Early HIV Infection
    Charles Bradley Hare, Brandee L. Pappalardo, Michael Paul Busch, Annika C. Karlsson, Bruce H. Phelps, S Alexander, Christopher G. Bentsen, Clarissa A. Ramstead, Douglas F. Nixon, Jay A. Levy et al. · 2006 · Clinical Infectious Diseases
63. Induction of TAK (Cyclin T1/P-TEFb) in Purified Resting CD4 + T Lymphocytes by Combination of Cytokines
    Romi Ghose, Li‐Ying Liou, Christine H. Herrmann, Andrew P. Rice · 2001 · Journal of Virology
64. Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
    Jonathan Karn, Uri R. Mbonye · 2011 · Current HIV Research
65. Inhibiting the HIV Integration Process: Past, Present, and the Future
    Roberto Di Santo · 2013 · Journal of Medicinal Chemistry
66. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir
    Vincent H. Wu, Jayme M.L. Nordin, Son Nguyen, Jaimy P. Joy, Felicity Mampe, Perla M. Del Río Estrada, Fernanda Torres-Ruiz, Mauricio González-Navarro, Yara Andrea Luna-Villalobos, Santiago Ávila‐Ríos et al. · 2022 · Nature Immunology
67. HIV Promoter Integration Site Primarily Modulates Transcriptional Burst Size Rather Than Frequency
    Ron Skupsky, John Burnett, Jonathan E. Foley, David V. Schaffer, Adam P. Arkin · 2010 · PLoS Computational Biology
68. Increased rates of CD4 + and CD8 + T lymphocyte turnover in simian immunodeficiency virus-infected macaques
    Michael Rosenzweig, MaryAnn DeMaria, David M. Harper, Stuart W. Friedrich, Rakesh K. Jain, R. Paul Johnson · 1998 · Proceedings of the National Academy of Sciences
69. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking?
    Yvonne J. Rosenberg, Arthur O. Anderson, Reinhard Pabst · 1998 · Immunology Today
70. Engaging innate immunity in HIV-1 cure strategies
    Nathan L. Board, Milica Moskovljevic, Fengting Wu, Robert F. Siliciano, Janet D'Angelo Siliciano · 2021 · Nature reviews. Immunology
71. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection
    Boris Kantor, Hong Ma, Jennifer Y. Webster-Cyriaque, Paul Edward Monahan, Tal Kafri · 2009 · Proceedings of the National Academy of Sciences
72. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ–NF-κB signaling
    Guochun Jiang, Érica Araújo Mendes, Philipp Kaiser, Sumathi Sankaran‐Walters, Yuyang Tang, Mariana G. Weber, GREGORY P. MELCHER, George R. Thompson, Amílcar Tanuri, Luiz Francisco Pianowski et al. · 2014 · AIDS
73. Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
    Barbara Ensoli, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Vittorio Francavilla, Simone Marcotullio, Aurelio Cafaro, Orietta Picconi, Giovanni Paniccia, Arianna Scoglio et al. · 2010 · PLoS ONE
74. HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
    Deanna A. Kulpa, Nicolas Chomont · 2015 · Journal of Virus Eradication
75. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes
    Jean-François Gagné, André Désormeaux, Sylvie Perron, Michel J. Tremblay, Michel G. Bergeron · 2002 · Biochimica et Biophysica Acta (BBA) - Biomembranes
76. Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials
    Angela M. Mexas, Erin H. Graf, Matthew J. Pace, Jianqing J. Yu, Emmanouil Papasavvas, Livio Azzoni, Michael Paul Busch, Michele Di Mascio, Andrea S. Foulkes, Stephen A. Migueles et al. · 2012 · AIDS
77. Measuring the Frequency of Latent HIV-1 in Resting CD4+ T Cells Using a Limiting Dilution Coculture Assay
    Gregory M. Laird, Daniel I. S. Rosenbloom, Jun Lai, Robert F. Siliciano, Janet D'Angelo Siliciano · 2015 · Methods in molecular biology
78. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
    Alexandra M. Bender, Francesco Roberto Simonetti, Mithra R. Kumar, Emily J. Fray, Katherine M. Bruner, Andrew E. Timmons, Katherine Yuxi Tai, Katharine M. Jenike, Annukka A.R. Antar, Po-Ting Liu et al. · 2019 · Cell Host & Microbe
79. Evaluation of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance Testing
    Amanda M. McNulty, Cheryl Jennings, Diane Bennett, Joseph E. Fitzgibbon, James W. Bremer, Michael A. Ussery, Marcia L. Kalish, Walid Heneine, Jose Gerardo Garcia-Lerma · 2006 · Journal of Clinical Microbiology
80. Dual Role of Prostratin in Inhibition of Infection and Reactivation of Human Immunodeficiency Virus from Latency in Primary Blood Lymphocytes and Lymphoid Tissue
    Angélique Biancotto, Jean‐Charles Grivel, Françoise Gondois‐Rey, Lise Bettendroffer, Robert Vigne, Stephen Brown, Leonid B Margolis, Ivan Hirsch · 2004 · Journal of Virology
81. Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication
    Roger J. Pomerantz · 2002 · Clinical Infectious Diseases
82. Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers
    Vincent Vieillard, Hugues Fausther‐Bovendo, Assia Samri, Patrice Debré · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
83. Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues
    Rob J. de Boer, Ruy Miguel Ribeiro, Alan S. Perelson · 2010 · PLoS Computational Biology
84. Novel Nuclear Import of Vpr Promoted by Importin α Is Crucial for Human Immunodeficiency Virus Type 1 Replication in Macrophages
    Yuko Nitahara‐Kasahara, Masakazu Kamata, Takuya Yamamoto, Xianfeng Zhang, Yoichi Miyamoto, Koho Muneta, Sayuki Iijima, Yoshihiro Yoneda, Yasuko Tsunetsugu‐Yokota, Yoko Aida · 2007 · Journal of Virology
85. The Susceptibility to X4 and R5 Human Immunodeficiency Virus-1 Strains of Dendritic Cells Derived In Vitro From CD34+ Hematopoietic Progenitor Cells Is Primarily Determined by Their Maturation Stage
    Bruno Canque, Youssef Bakri, Sandrine Camus, Micaël Yagello, Abdelaziz Benjouad, Jean Claude Gluckman · 1999 · Blood
86. A Large U3 Deletion Causes Increased In Vivo Expression from a Nonintegrating Lentiviral Vector
    Bayer, Matthew, Kantor, Boris, Cockrell, Adam, Ma, Hong, Zeithaml, Brian, Li, Xiangping, McCown, Thomas, Kafri, Tal · 2008 · Molecular Therapy
87. A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir
    Claire Levy, Sean M. Hughes, Pavitra Roychoudhury, Daniel B. Reeves, Chelsea Amstuz, Haiying Zhu, Meei-Li W. Huang, Yulun Wei, Marta E. Bull, Noah A.J. Cassidy et al. · 2021 · Cell Reports Medicine
88. The multifaceted nature of HIV latency
    Caroline Dufour, Pierre Gantner, Rémi Fromentin, Nicolas Chomont · 2020 · Journal of Clinical Investigation
89. Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironments
    Sizun Jiang, Chi Ngai Chan, Xavier Rovira‐Clavé, Han M. Chen, Yunhao Bai, Bokai Zhu, Erin McCaffrey, Noah F. Greenwald, Candace C. Liu, Graham L. Barlow et al. · 2021 · Immunity
90. Resting Regulatory CD4 T Cells: A Site of HIV Persistence in Patients on Long-Term Effective Antiretroviral Therapy
    Tú-Anh Tran, Marie-Ghislaine de Goër de Herve, Houria Hendel, Bamory Dembelé, Emilie le Névot, Karim Abbed, Coralie Pallier, Cécile Goujard, Jacques Gasnault, Jean‐François Delfraissy et al. · 2008 · PLoS ONE
91. Different human resting memory CD4 + T cell subsets show similar low inducibility of latent HIV-1 proviruses
    Kyungyoon J. Kwon, Andrew E. Timmons, Srona Sengupta, Francesco Roberto Simonetti, Hao Zhang, Rebecca Hoh, Steven G. Deeks, Janet D'Angelo Siliciano, Robert F. Siliciano · 2020 · Science Translational Medicine
92. Comprehensive analysis of unique cases with extraordinary control over HIV replication
    Daniel Mendoza, Sarah Johnson, Bennett A. Peterson, Ven Natarajan, María Salgado, Robin L. Dewar, Peter D. Burbelo, Nicole A. Doria‐Rose, Erin H. Graf, Jamieson H. Greenwald et al. · 2012 · Blood
93. Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load
    Leondios G. Kostrikis, Giota Touloumi, Rose Karanicolas, Nikos Pantazis, Cleo G. Anastassopoulou, Anastasia Karafoulidou, James J. Goedert, Angelos E. Hatzakis · 2002 · Journal of Virology
94. Immunological approaches to HIV cure
    Adam R. Ward, Talia M. Mota, Richard Brad Jones · 2020 · Seminars in Immunology
95. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells
    Suha M. Saleh, Fiona Wightman, Saumya Ramanayake, Marina R. Alexander, Nitasha Kumar, Gabriela Khoury, Cândida F. Pereira, Damian F. J. Purcell, Paul U. Cameron, Sharon R. Lewin · 2011 · Retrovirology
96. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells
    Alberto Bosque, Vicente Planelles · 2010 · Methods
97. How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle
    Lingappa, Jaisri R., Reed, Jonathan C., Tanaka, Motoko, Chutiraka, Kasana, Robinson, Bridget A. · 2014 · Virus Research
98. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
    Silvia Bertagnolio, Neil T. Parkin, Michael R. Jordan, James Brooks, Jose Gerardo Garcia-Lerma · 2010 · PubMed
99. Developing strategies for HIV-1 eradication
    Christine M. Durand, Joel N. Blankson, Robert F. Siliciano · 2012 · Trends in Immunology
100. In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure
     Janet D'Angelo Siliciano, Robert F. Siliciano · 2021 · Annual Review of Pathology Mechanisms of Disease